| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Nov 14, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 17.5 | -25,484 | -76.42% | ✗ | $1.7M |
| Jun 26, 2025 | Jun 30, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 22.5 | -4,707 | -37.45% | ✗ | $207.3K |
| Dec 29, 2021 | Jun 30, 2025 | BridgeBio Pharma, Inc. | Director | Buy | 91.3 | +1,752 | 41.43% | ✗ | $24.9K |
| Dec 28, 2021 | Jun 30, 2025 | BridgeBio Pharma, Inc. | Director | Buy | 91.3 | +2,338 | 123.64% | ✗ | $30K |
| Jun 18, 2025 | Jun 23, 2025 | CareDx, Inc. | Director | Sell | 15.0 | -10,570 | -21.33% | ✓ | $202.6K |
| Jun 10, 2025 | Jun 11, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 10.0 | -4,292 | -45.23% | ✓ | $171.7K |
| Mar 6, 2025 | Mar 10, 2025 | BridgeBio Pharma, Inc. | Director | Sell | 7.5 | -12,875 | -71.24% | ✓ | $419.5K |
| Feb 15, 2024 | Feb 20, 2024 | BridgeBio Pharma, Inc. | Director | Sell | 10.0 | -2,915 | -35.93% | ✓ | $110K |
| Dec 28, 2021 | Feb 13, 2024 | BridgeBio Pharma, Inc. | Director | Buy | 91.3 | +3,433 | 194.61% | ✗ | $44.5K |
| Dec 28, 2021 | Feb 13, 2024 | BridgeBio Pharma, Inc. | Director | Buy | 91.3 | +3,433 | 100.00% | ✗ | $44.5K |
| Jan 16, 2024 | Jan 18, 2024 | BridgeBio Pharma, Inc. | Director | Sell | 10.0 | -2,915 | -62.30% | ✓ | $110.7K |
| Dec 15, 2023 | Dec 19, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 10.0 | -2,915 | -62.30% | ✓ | $105.3K |
| Nov 15, 2023 | Nov 17, 2023 | BridgeBio Pharma, Inc. | Director | Sell | 10.0 | -2,915 | -62.30% | ✓ | $87.5K |
| Dec 29, 2021 | Jan 3, 2022 | BridgeBio Pharma, Inc. | Director | Buy | 91.3 | +1,764 | 100.00% | ✗ | $25.1K |